论文部分内容阅读
来自中国的企业深圳迈瑞生物医疗电子股份有限公司越来越让它的国际对手们——GE、飞利浦、东芝、西门子这些响当当的跨国巨头们如芒在背。他们所担忧的,当然不是去年9月迈瑞在纽交所的成功上市,毕竟从资金实力比,这家中国公司远远不是他们的对手。令他们深感不安的,是它的创新能力——迈瑞推出新产品的速度非常之快,其自主研发生产的系列高科技医疗设备,不仅性能卓越,而且价格也比这些国际巨头低得多。
More and more international rivals, GE, Philips, Toshiba and Siemens, multinational giants such as Mengrui Biomedical Electronics Co., Ltd., a Shenzhen-based company from China, are back in power. What they are worried about is certainly not the successful listing of Mindray on the NYSE in September last year. After all, from a financial strength, the Chinese company is far from their rival. What makes them uncomfortable is its ability to innovate - Mindray launched a new product very fast, its own series of high-tech research and development of medical equipment, not only superior performance, but the price is much lower than these international giants.